2 reports

  • (EXENATIDE + GLUCAGON) - DRUG PROFILE

Obesity - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Pipeline Review, H1 2018, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape. Obesity is defined as having an excessive amount...

  • Diabetes
  • Obesity
  • Pathology
  • Pharmaceutical
  • Therapy
  • Drug Profiles

Glucagon-like peptide is a glucagon-like peptide-## receptor agonist.

  • Chronic Disease
  • Diabetes
  • Insulin
  • Pathology
  • Research And Development